Data as of 1:53pm ET
| +0.12 / +0.57%|
The 4 analysts offering 12-month price forecasts for Auspex Pharmaceuticals Inc have a median target of 41.00, with a high estimate of 42.00 and a low estimate of 40.00. The median estimate represents a +92.13% increase from the last price of 21.34.
The current consensus among 4 polled investment analysts is to Buy stock in Auspex Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.